Trial Profile
Observational study on evaluation of glycaemic control in patients using a modern insulin - NovoRapid (insulin aspart), NovoMix 30 (biphasic insulin aspart) or Levemir (insulin detemir) - for treatment of diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart (Primary) ; Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COMMIT-CLEAN-SWITCH
- Sponsors Novo Nordisk
- 19 Apr 2011 Planned end date changed from 1 Apr 2011 to 1 May 2010 as reported by ClinicalTrials.gov.
- 19 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.